DIPG

Clinical trials for DIPG explained in plain language.

Never miss a new study

Get alerted when new DIPG trials appear

Sign up with your email to follow new studies for DIPG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Promising combo targets Hard-to-Treat childhood cancers

Disease control Recruiting now

This study is testing a combination of two drugs—a targeted radioactive drug (177Lu-DOTATATE) and a PARP inhibitor (olaparib)—in children and teens aged 3 to 18 with certain solid tumors that have come back or not responded to treatment. The goal is to see if the combination is s…

Matched conditions: DIPG

Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

DIPG

Get alerted when new DIPG trials appear

Promising combo targets Hard-to-Treat childhood cancers